Novartis sues Amgen over collaboration on migraine treatment Aimovig

Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of trying to wrongfully back out of agreements to jointly develop and market migraine prevention drug Aimovig, and keep the profits for itself.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news